This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2022 Information Coming Soon!

Johan Lantto, PhD
Project and Portfolio Director at Symphogen


Dr. Lantto is a Project & Portfolio Director at Symphogen, a Servier company based in Denmark. Dr. Lantto holds a Ph.D. in Immunotechnology from Lund University, Sweden, where he studied antibody evolution and repertoire development. Dr. Lantto has more than 20 years of experience with antibody engineering and the development of therapeutic antibodies. For the past 17 years, Dr. Lantto has worked for Symphogen where he has been involved in the development of the company’s Symplex™ antibody discovery platform as well as been responsible for antibody drug discovery and development projects within infectious disease and oncology. Dr. Lantto has been responsible for six oncology projects that have been brought to the clinic by Symphogen.

Agenda Sessions

  • Advantages and Challenges of Chicken-derived Therapeutic Antibodies

    On Demand
  • Antibody Screening, Discovery and Technology